Cargando…
Generation of induced neural stem cells with inducible IDH1(R132H) for analysis of glioma development and drug testing
Mutation in isocitrate dehydrogenase 1 (IDH1(R132H)) occurs in various types of cancer, including low and high grade gliomas. Despite high incidence indicating its central role in tumor initiation and progression there are no targeted therapies directed against this oncogene available in the clinic....
Autores principales: | Rosiak-Stec, Kamila, Grot, Dagmara, Rieske, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500637/ https://www.ncbi.nlm.nih.gov/pubmed/32946483 http://dx.doi.org/10.1371/journal.pone.0239325 |
Ejemplares similares
-
IDH1(R132H) in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis
por: Rosiak, Kamila, et al.
Publicado: (2016) -
IDH-1(R132H) mutation status in diffuse glioma patients: implications for classification
por: Wang, Peng-fei, et al.
Publicado: (2016) -
Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016) -
R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition
por: Sears, Thomas K., et al.
Publicado: (2022) -
Generation and Performance of R132H Mutant IDH1 Rabbit Monoclonal Antibody
por: Rashidian, Juliet, et al.
Publicado: (2017)